A Randomized Open Blind Control Study Assessing Clopidogrel Resistance in Iranian Patients Undergoing Percutaneous Coronary Intervention in Rajaie Heart Center

AUTHORS

Hosein ali Basiri 1 , * , Bahram Fariborz Farsad 1 , **

1 Iran

Corresponding Authors:

How to Cite: Basiri H A , Farsad B F. A Randomized Open Blind Control Study Assessing Clopidogrel Resistance in Iranian Patients Undergoing Percutaneous Coronary Intervention in Rajaie Heart Center, Multidiscip Cardio Annal. 2012 ; 4(2):e8771.

ARTICLE INFORMATION

Multidisciplinary Cardiovascular Annals: 4 (2); e8771
Published Online: July 25, 2012
Article Type: Research Article
Received: September 12, 2016
Accepted: July 12, 2012

Crossmark

CHEKING

READ FULL TEXT
Abstract

The prevalence of response variability to clopidogrel in Iranian patients undergoing
elective percutaneous coronary intervention (PCI) with stenting, impleta has not been
fully investigated. We evaluated clopidogrel antiplatelet effects of 300 mg versus a 450
mg in open blind randomized clinical trial in a referral teaching hospital in Iran.

Keywords

A Randomized,Percutaneous Coronary

© 0, Multidisciplinary Cardiovascular Annals. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.

Fulltext

Full Text Available is PDF

References

  • 1.

    Full Text Available is PDF

  • COMMENTS

    LEAVE A COMMENT HERE: